Seaport Global Downgrades Evergy to Neutral

Seaport Global analyst Angie Storozynski downgrades Evergy (NYSE:EVRG) from Buy to Neutral.

Seaport Global analyst Angie Storozynski downgrades Evergy (NYSE:EVRG) from Buy to Neutral.

Total
0
Shares
Related Posts
Read More

Lixte Biotechnology Holdings Reports That Its Lead Clinical Compound, LB-100, Can Kill Cancer Cells Through Hyper-Stimulation Of Cell Proliferation Signals In Pre-Clinical Models; Shares Halted On Circuit Breaker To The Upside

--THE STUDY ESTABLISHES A NOVEL CONCEPT OF "TUMOR SUPPRESSIVE DRUG RESISTANCE"   --THE COMBINATION OF LB-100 WITH INHIBITORS OF CELLULAR STRESS RESPONSE MODULATORS WAS HIGHLY EFFECTIVE IN

LIXT